No information is available on the clinical use of abrocitinib during breastfeeding. The manufacturer recommends that breastfeeding be discontinued during abrocitinib therapy and for 1 day after the last dose.
关于阿巴西普替尼在母乳喂养期间的临床应用尚无可用信息。制造商建议在阿巴西普替尼治疗期间及最后一剂后1天停止母乳喂养。
